A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers
Ocellaris Pharma, Inc.
Ocellaris Pharma, Inc.
Mayo Clinic
Numab Therapeutics AG
Pfizer
Sinocelltech Ltd.
Seagen Inc.
Wuhan University
Rain Oncology Inc
Amgen
M.D. Anderson Cancer Center
Hoffmann-La Roche
M.D. Anderson Cancer Center
Merck Sharp & Dohme LLC
Dana-Farber Cancer Institute
Pfizer
Pfizer